³ëµ¿¿µ ¹Ú»ç Q&A
¹Ú»ç´Ô »ó´ãÄÚ³Ê
¹Ú»ç´Ô ¾à·Â
ºñ³Ê½º Ä®·³
ÀÚÁÖ¹¯´Â Áú¹®
¹Ú»ç´Ô »ó´ãÄÚ³Ê
Àǽɽº·¯¿î Áõ»óÀ̳ª, ¼ö¼ú ÀüÈÄÀÇ ÈÄÀ¯Áõ µî ±Ã±ÝÇÏ°í ´ä´äÇÑ °í¹Î°Å¸®¸¦ ³ëµ¿¿µ ¹Ú»ç´ÔÀÌ Á÷Á¢ »ó´ãÇØ µå¸³´Ï´Ù.
ÀÚ½ÅÀÇ °í¹Î°ú ºñ½ÁÇÑ ´Ù¸¥ »ç¶÷ÀÇ ±Û·Îµµ ÇÑ´«¿¡ ¾Ë±â ½±µµ·Ï Q&A°¡ µµ¿Íµå¸± °ÍÀÔ´Ï´Ù.
¹®Àǵ帳´Ï´Ù.
ÀÛ¼ºÀÚ : ... ÀÛ¼ºÀÏ : 2019-02-02 [09:59]Á¶È¸ : 322
³ªÀÌ: 41¼¼

(Á¶Á÷°Ë»ç °á°úÁö)

Tumor size : 0.8¡¿0.7
Ductal carcinoma in suit : low grade
Tubular differentiation : 2/3
Nuclear pleomorphism : 2/3
Mitotic count : 1/3
¸²ÇÁÀý ÀüÀÌ ¾øÀ½

P63=negative
CK5/6=positive
ER=+allred score =5 (%staining score3, intensity score2)
PR=- allred score 0
Her2/neu= -/3
Ki-67 = + (<10%)
EGFR = ++/3

ÀÌ·± »óȲ¿¡¼­ ¿ÂÄÚŸÀÔÀ» ÀÇ·ÚÇß¾ú´Âµ¥ Èñ±Í À¯¹æ¾ÏÀ¸·Î ÆǸí? ºÒ°¡·Î ³ª¿Ô¾î¿ä ¤Ð¤Ð (Àǻ缱»ý´Ôµµ ¿ÂÄÚŸÀÔ¿¡¼­ ºÒ°¡ ³ª¿Â »óȲÀº óÀ½º¸¼Ì´Ù³×¿ä)

Á© óÀ½ Á¶Á÷ °Ë»çÇßÀ»½Ã ring cell carcinoma µµ ¾ÆÁÖ ¹Ì¼¼ÇÏ°Ô º¸Àδٰí Çß¾ú´Âµ¥ ¸·»ó ¼ö¼ú ÇÏ°í Á¶Á÷À» ¶¼¼­ º¸´Ï ring cell carcinoma ´Â ¾È º¸¿´³ªºÁ¿ä. ±×·¡¼­ ¿ÂÄÚŸÀÔ¿¡ ÀÇ·Ú¸¦ Çߴµ¥ ±× ±â°ü¿¡¼­ ´Ù¸¥ Èñ±ÍŸÀÔ (±×°Ç ¹ºÁö ¸ð¸£°Ú¾î¿ä ¤Ð) ³ª¿Ô´Ù´Â ¼Ò°ßÀ» ¹Þ¾Ò´ä´Ï´Ù.
Ç×¾Ï Ä¡·á ¿©ºÎ¸¦ ÀÌÁ¦ °áÁ¤ÇؾßÇÏ´Â ½ÃÁ¡Àε¥ ´ã´çÀÇ»ç ¼±»ý´Ôµµ Á¤È®È÷ ÆÇ´ÜÀÌ ¾ÈµÇ½Ã³ªºÁ¿ä..¤Ð¤Ð
ÀÌ·² °æ¿ì ¾î¶»°Ô ÇؾßÇÒÁö Âü È¥¶õ½º·´½À´Ï´Ù.
¼±»ý´Ô ÀÇ°ßµµ µè°í ½Í¾î¼­ ¹®Àǵ帳´Ï´Ù.
°¨»çÇÕ´Ï´Ù

»õÇØ º¹ ¸¹ÀÌ ¹ÞÀ¸¼¼¿ä

¼öÁ¤»èÁ¦´äº¯ÀÛ¼º¸ñ·Ï
¹øÈ£
Á¦¸ñ
ÀÛ¼ºÀÚ
ÀÛ¼ºÀÏ
Á¶È¸
53215
±³¼ö´Ô ¿ìÃøÀüÀýÁ¦Àε¥ ÁÖ»ç¸Â¾ÆµµµÇ³ª¿ä?
2024-03-21 254
53214
ÀüÀýÁ¦ ¼ö¼ú ½Ã À¯¹æÇÇºÎ¿Í À¯µÎ´Â?
±×·¹À̽º 2024-03-20 106
53213
ÀüÀýÁ¦ ¼ö¼ú ½Ã À¯¹æÇÇºÎ¿Í À¯µÎ´Â?
2024-03-20 247
53212
¹æ»ç¼±Ä¡·á ¿Í ºñ¿Àƾ
ÀÌÁö¼ö 2024-03-19 129
53211
¹æ»ç¼±Ä¡·á ¿Í ºñ¿Àƾ
2024-03-19 285
53210
¾Æ¸óµå°¡·ç
¿ÀƼ¿ò 2024-03-19 119
53209
¾Æ¸óµå°¡·ç
2024-03-19 274
53208
°¡½¿Â
ÈÆ´Ù¸¾ 2024-03-18 104
53207
°¡½¿Â
2024-03-19 246
53206
¾î¸Ó´ÏÀÇ À¯¹æ¾Ï
°ÆÁ¤¿¡´Ä´Âµþ 2024-03-18 140
53205
¾î¸Ó´ÏÀÇ À¯¹æ¾Ï
2024-03-19 279
53204
Ÿ¸ñ½ÃÆæ º¹¿ë°ú ¾Æ·§¹èÅëÁõ
±èÁöÀº 2024-03-18 136
53203
Ÿ¸ñ½ÃÆæ º¹¿ë°ú ¾Æ·§¹èÅëÁõ
2024-03-19 217
53202
¼ö¼ú¹æ¹ý¿¡´ëÇؼ­¹®Àǵ帳´Ï´Ù
ÈÆÀ̸¾ 2024-03-18 109
12345678910+10¸¶Áö¸·
 
ÀÛ¼º¸ñ·Ï